| Followers | 22 |
| Posts | 2360 |
| Boards Moderated | 1 |
| Alias Born | 09/27/2020 |
Wednesday, September 25, 2024 12:10:53 PM
Recent NVAX News
- Novavax shares gain after Matrix-M adjuvant licensing deal with Pfizer • IH Market News • 01/20/2026 02:48:06 PM
- Novavax Announces Entering into a License Agreement with Pfizer • PR Newswire (US) • 01/20/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 11:59:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:01:06 PM
- Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/07/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 09:01:11 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/12/2025 09:17:57 PM
- Novavax to Participate in Jefferies London Healthcare Conference • PR Newswire (US) • 11/12/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 01:00:22 PM
- Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights • PR Newswire (US) • 11/06/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 12:47:47 PM
- Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment • PR Newswire (US) • 11/04/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 11:02:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2025 08:30:19 PM
- Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 • PR Newswire (US) • 10/30/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2025 11:00:50 AM
- Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy • PR Newswire (US) • 10/22/2025 11:00:00 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/14/2025 11:45:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 11:00:33 AM
- Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment • PR Newswire (US) • 10/07/2025 11:00:00 AM
- Novavax Announces Progress on Sanofi Agreement • PR Newswire (US) • 09/30/2025 01:01:00 PM
- Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment • PR Newswire (US) • 09/04/2025 12:00:00 PM
- Novavax to Participate in the Cantor Global Healthcare Conference • PR Newswire (US) • 09/03/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2025 08:40:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2025 08:38:26 PM
FEATURED Envirotech Vehicles Reaffirms Momentum With AZIO AI and Provides Update on Nasdaq Compliance Process • Jan 21, 2026 1:25 PM
Rainmaker Worldwide Expands U.S. Operations With ATMOCELL 5K and R/OCell® Deployments in the Permian Basin • RAKR • Jan 20, 2026 11:15 AM
One World Products Appoints Filmoore Walker as Chief Operating Officer • OWPC • Jan 20, 2026 11:14 AM
OTC Markets Group Welcomes ConnectM Technology Solutions, Inc. to OTCQX • CNTM • Jan 20, 2026 9:45 AM
From Permits to Pouring Gold: The Power of Being Production-Ready • B • Jan 20, 2026 9:00 AM
Rainmaker Worldwide Inc. Announces Settlement Agreement Resolving Legacy Debt Obligation • RAKR • Jan 15, 2026 10:35 AM
